CRISPR/Cas9 technology to inactivate cancer mutations, say scientists
Thursday, September 1, 2016 - 05:01
in Biology & Nature
As for many other biomedical and biotechnology disciplines, the genome scissor 'CRISPR/Cas9' also opens up completely new possibilities for cancer research. Scientists have shown that mutations that act as cancer drivers can be targeted and repaired. The most relevant mutations could therefore be diagnosed faster, improving personalized therapies.
